Status:
ACTIVE_NOT_RECRUITING
Quality of Life in Patients With Bladder Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
Albert Einstein College of Medicine
Northwell Health
Conditions:
Bladder Cancer
Eligibility:
All Genders
18-99 years
Brief Summary
The purpose of this study is to learn about the quality of life of people living with bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan t...
Eligibility Criteria
Inclusion
- All patients (male and female) who are diagnosed with bladder cancer
- Patients must be scheduled for radical cystectomy and urinary diversion are and/or being evaluated for neo-adjuvant chemotherapy prior to a planned cystectomy.
- Participants must be able to speak English.
- Participants must be able to provide informed consent.
- Participants must be 18 years of age or older to enroll.
- Participant may be eligible for and may receive neoadjuvant or adjuvant chemotherapy.
- Participant may have had intravesicle chemotherapy or immunotherapy (BCG, Interferon).
Exclusion
- Subjects may be excluded from the study based on the following criteria:
- Follow-up care not obtained at MSKCC.
- Metastatic disease at diagnosis.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT00745355
Start Date
August 1 2008
End Date
August 1 2026
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065